What's Old Is New: Former Commissioners and the Future of FDA
This article was originally published in RPM Report
Executive Summary
Four ex-commissioners outline their ideas for reforming the Food & Drug Administration. They don't think new ideas are necessary: just follow through on their old favorites.
You may also be interested in...
Former FDA Commissioner Donald Kennedy: Lessons From A Different Era
Donald Kennedy has passed away after contracting COVID-19 in a nursing home. Even 40 years after he ran FDA, a remarkable number of themes of his tenure still resonate.
Building the Right Foundation: An Interview with Mark McClellan
The Reagan-Udall Foundation is an early priority for FDA in implementing the landmark legislation enacted by Congress in 2007. It is also a lightning road for criticism from Congress about the agency's relationship with regulated industry. We asked foundation chairman Mark McClellan for a status report.
Nickel and Diming FDA
Everyone agrees FDA needs more money to do its job. Its not getting it. Does that mean the drug safety law will just end up making a bad situation worse?